Coxsackie B (1-6) Antibodies, (CSF)
The coxsackie group virus are named so as they were isolated from stool samples of children living in Coxsackie, New York in 1948. It has 30 different serotypes that cause different symptoms among children. Serotypes are divided into two groups based on their pathogenicity and antigenicity: Coxsackie A and Coxsackie B. Coxsackie A has 24 serotypes while Coxsackie B has 6 serotypes (B1-B6). The mode of transmission is mainly the fecal-oral route which colonizes in the intestinal tract and later replicates in lymphoid tissues of the nasopharynx.
Coxsackie B virus infections are often asymptomatic or result in an undifferentiated febrile illness. In more serious cases, aseptic meningitis, encephalomyelitis, pleurodynia and/or myocarditis may occur. IgA, IgG and IgM antibodies are produced in response to infection and can be detected in serum and cerebrospinal fluid.
- Demonstration of Coxsackie B (1-6) antibody in CSF aids in diagnosis of Coxsackie B virus meningitis or encephalomyelitis
Less 1:1 (in all B1-B6)
Cerebrospinal fluid.
Stability
- Ambient: 24 hours
- Refrigerated: 3-5 days
- Frozen: 30 days
- JAMA. 1958; 168: 264-7. [PMID: 13575151]
- BMJ. 199; 302: 140-3 [PMID: 1847316]
- J Am Med Assoc. 1954 Oct 16;156(7):676-9. [PMID: 13201369]
- Jpn Circ J. 1989; 53: 87-93 [PMID: 2541266]